卫宁健康 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	2.8B	3.2B	3.1B	2.8B	2.3B
Revenue Growth %	-12.0%	2.3%	12.5%	21.3%	--
Total Revenue	2.8B	3.2B	3.1B	2.8B	2.3B
Cost Of Revenue	1.6B	1.7B	1.7B	1.5B	1.0B
+Gross Profit	1.2B	1.4B	1.4B	1.3B	1.2B
Gross Margin %	41.7%	45.0%	43.7%	46.3%	54.1%
Total Operating Cost	2.8B	3.0B	3.1B	2.6B	1.9B
Selling Expenses	343.0M	458.0M	496.0M	387.0M	319.0M
Admin Expenses	202.0M	195.0M	212.0M	199.0M	145.0M
Rd Expenses	265.0M	333.0M	314.0M	256.0M	229.0M
Finance Expenses	57.4M	51.1M	39.7M	35.5M	5.7M
+Operating Income	87.2M	341.0M	39.5M	375.0M	552.0M
Operating Margin %	3.1%	10.8%	1.3%	13.6%	24.3%
Non Operating Income	363,900	233,200	33,800	301,500	84,400
Non Operating Expenses	577,400	917,000	994,600	1.8M	5.6M
Investment Income	-48.2M	29.5M	-65.7M	-39.0M	101.0M
Fair Value Change Income	-28.6M	-50.5M	-24.9M	156.0M	-34.7M
Asset Disposal Income	-279,400	-425,800	-518,000	176,800	227,100
Asset Impairment Loss	169.0M	137.0M	129.0M	83.9M	81.9M
Other Income	151.0M	153.0M	137.0M	140.0M	125.0M
Income Before Tax	87.0M	341.0M	38.5M	373.0M	546.0M
Income Tax	36.9M	23.1M	23.8M	19.4M	40.6M
+Net Income	50.1M	318.0M	14.8M	354.0M	506.0M
Net Margin %	1.8%	10.1%	0.5%	12.9%	22.3%
Net Income Attributable	87.9M	358.0M	109.0M	378.0M	491.0M
Minority Interest	-37.8M	-40.3M	-93.9M	-24.4M	14.4M
Eps Basic	0.04	0.17	0.05	0.18	0.23
Eps Diluted	0.04	0.16	0.05	0.18	0.23

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.3B	1.1B	1.3B	1.6B	989.0M
Trading Financial Assets	3.0M	--	--	--	--
Accounts Receivable	1.2B	1.1B	931.0M	708.0M	585.0M
Notes Receivable	11.0M	18.3M	8.8M	18.7M	7.5M
Notes And Accounts Receivable	1.2B	1.1B	940.0M	726.0M	592.0M
Prepayments	90.2M	81.3M	58.3M	35.9M	38.8M
Inventory	111.0M	111.0M	97.5M	133.0M	128.0M
Total Current Assets	5.1B	4.9B	4.3B	4.2B	3.2B
Long Term Equity Investment	490.0M	499.0M	494.0M	511.0M	530.0M
Fixed Assets	--	481.0M	491.0M	502.0M	465.0M
Fixed Assets Total	469.0M	481.0M	491.0M	502.0M	465.0M
Construction In Progress	--	--	--	1.3M	--
Construction In Progress Total	--	--	--	1.3M	--
Intangible Assets	1.1B	1.0B	505.0M	584.0M	341.0M
Long Term Deferred Expenses	10.1M	11.8M	16.2M	13.1M	6.7M
Total Non Current Assets	3.7B	3.7B	3.5B	3.3B	2.8B
Total Assets	8.8B	8.5B	7.8B	7.5B	6.1B
Short Term Borrowings	40.3M	58.0M	42.9M	--	214.0M
Accounts Payable	698.0M	674.0M	603.0M	495.0M	394.0M
Advance Receipts	--	--	--	--	--
Contract Liabilities	141.0M	145.0M	194.0M	203.0M	160.0M
Total Current Liabilities	1.6B	1.7B	1.6B	1.3B	1.2B
Total Non Current Liabilities	1.2B	1.2B	1.1B	1.0B	114.0M
Total Liabilities	2.8B	2.9B	2.7B	2.3B	1.3B
Paid In Capital	2.2B	2.2B	2.1B	2.1B	2.1B
Capital Reserve	1.1B	872.0M	636.0M	572.0M	486.0M
Surplus Reserve	254.0M	251.0M	226.0M	217.0M	187.0M
Retained Earnings	2.5B	2.4B	2.1B	2.1B	1.8B
Minority Equity	-28.0M	-5.8M	16.8M	73.5M	192.0M
Equity Attributable	6.0B	5.7B	5.1B	5.1B	4.5B
Total Equity	5.9B	5.7B	5.1B	5.2B	4.7B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	2.8B	2.7B	2.7B	2.5B	2.0B
Tax Refunds Received	130.0M	124.0M	93.8M	95.6M	108.0M
Total Operating Cash Inflow	3.7B	3.6B	3.5B	3.0B	2.2B
Cash Paid For Goods	1.0B	1.0B	1.2B	987.0M	562.0M
Cash Paid To Employees	1.0B	1.1B	1.0B	819.0M	639.0M
Taxes Paid	291.0M	247.0M	212.0M	213.0M	198.0M
Total Operating Cash Outflow	3.3B	3.4B	3.4B	2.6B	1.9B
Operating Cash Flow	408.0M	185.0M	100.0M	368.0M	390.0M
Total Investing Cash Inflow	9.0M	90.0M	18.1M	24.5M	131.0M
Total Investing Cash Outflow	309.0M	360.0M	368.0M	367.0M	217.0M
Investing Cash Flow	-300.0M	-270.0M	-350.0M	-343.0M	-86.1M
Cash From Borrowings	48.5M	36.5M	42.8M	961.0M	332.0M
Dividends And Interest Paid	54.9M	34.0M	49.3M	67.6M	51.2M
Debt Repayments	66.0M	17.0M	--	213.0M	342.0M
Total Financing Cash Inflow	366.0M	65.4M	147.0M	1.1B	413.0M
Total Financing Cash Outflow	244.0M	134.0M	267.0M	557.0M	457.0M
Financing Cash Flow	122.0M	-68.4M	-120.0M	576.0M	-43.7M
Net Change In Cash	229.0M	-154.0M	-369.0M	601.0M	261.0M
Ending Cash Balance	1.3B	1.0B	1.2B	1.6B	965.0M
Capex	306.0M	313.0M	324.0M	286.0M	187.0M